Matrix drug screening using a library of 1912 compounds crossed with birinapant found that histone deacetylase (HDAC) inhibitors (entinostat, panobinostat, vorinostat, romidepsin, and Trichostatin A) are highly synergistic with SMs in killing ovarian cancer cells [11]. Here, HDAC9 is linked to ovarian carcinoma.